Amlodipine: Side Effects and Contraindications

Amlodipine is one of the most widely prescribed blood pressure medications in the United States. Physically active people encounter it too, whether they have hypertension or are dealing with elevated blood pressure linked to heavy training, weight gain or anabolic steroid use. Our editors summarize the drug's safety profile, who should not take it, and what athletes in particular should know.

How amlodipine works

Amlodipine belongs to the dihydropyridine class of calcium channel blockers. It blocks L-type calcium channels in the smooth muscle of blood vessel walls, so less calcium enters the cells. As a result, the arteries relax and widen, lowering blood pressure.

Its effect on the heart muscle itself is relatively small compared with other calcium channel blockers such as verapamil and diltiazem. That is why amlodipine primarily acts as a vasodilator and does not usually slow the heart rate.

A defining feature is its long half-life, roughly 30–50 hours. This allows once-daily dosing and produces smooth, steady blood pressure control. It also means that effects and side effects build up over several days and fade gradually after stopping.

In the US, amlodipine is a prescription medicine approved by the FDA for hypertension and coronary artery disease, including chronic stable angina and vasospastic angina. According to the official labeling, the usual starting dose for adults is 5 mg once daily, with a maximum of 10 mg; lower starting doses are listed for small, fragile or elderly patients and those with liver impairment. Your prescriber decides the right dose.

Evidence for benefit

Amlodipine has been tested in large outcome trials. In ALLHAT, one of the largest hypertension trials ever conducted, amlodipine was compared with a thiazide-type diuretic and an ACE inhibitor in more than 33,000 patients. Rates of the primary coronary outcome were similar across groups, although heart failure was more frequent with amlodipine than with the diuretic.

The ASCOT-BPLA trial found that an amlodipine-based regimen reduced cardiovascular events and mortality compared with an atenolol-based regimen in hypertensive patients with additional risk factors.

Current US guidelines from the American College of Cardiology and American Heart Association list calcium channel blockers among first-line drug classes for hypertension, alongside thiazide diuretics, ACE inhibitors and angiotensin receptor blockers.

Controlling blood pressure protects the heart, brain, kidneys and blood vessels. For anyone with hypertension, the benefits of effective treatment typically outweigh the side effects, which are often manageable.

Common and serious side effects

Most side effects stem from the drug's vasodilating action. The most characteristic is peripheral edema, swelling of the ankles and lower legs. It is dose-dependent and more common in women. A meta-analysis by Makani and colleagues found that edema was a common reason for discontinuing dihydropyridine calcium channel blockers.

This swelling is not caused by fluid retention in the usual sense and often responds poorly to diuretics. It results from dilation of small arteries without matching dilation of veins, raising pressure in the capillaries. Combining amlodipine with an ACE inhibitor or ARB can reduce it.

Any chest pain, fainting, severe dizziness, signs of an allergic reaction or yellowing of the skin requires urgent medical attention.

Contraindications and precautions

The only absolute contraindication in the US labeling is known hypersensitivity to amlodipine. However, several conditions call for caution and close medical supervision.

A solid starting point is Buy Supplements for Muscle Building.

• Severe aortic stenosis: vasodilation can cause dangerous drops in blood pressure.
• Severe hypotension or shock: the drug can worsen low blood pressure.
• Heart failure: generally avoided unless specifically indicated, given trial data on heart failure events.
• Liver impairment: the drug is metabolized in the liver; levels may rise.
• Pregnancy and breastfeeding: use only if a physician judges benefits outweigh risks.
• Older adults: more sensitive to dizziness and falls.

Amlodipine is metabolized mainly by the liver enzyme CYP3A4. Strong CYP3A4 inhibitors, such as certain antifungals and HIV medications, can raise its levels. Grapefruit has a modest effect compared with some other calcium channel blockers.

The FDA has advised limiting simvastatin to 20 mg per day in patients taking amlodipine because of an increased risk of muscle injury. Combining amlodipine with other blood pressure drugs, erectile dysfunction medications or alcohol can enhance blood pressure lowering. Always give your doctor and pharmacist a full list of medications and supplements.

Notes for athletes and active people

Amlodipine is not on the WADA Prohibited List, so athletes with diagnosed hypertension can generally use it without a therapeutic use exemption. Still, it can affect training in practical ways.

Vasodilation, combined with heat, dehydration or a sudden stop after intense exercise, can cause dizziness or fainting. Cooling down gradually and staying well hydrated help. Ankle swelling may be more noticeable after long periods on your feet or in hot weather.

Some strength athletes develop high blood pressure linked to anabolic steroid use, stimulants or rapid weight gain. Self-medicating with amlodipine to mask this is dangerous: it does not address the underlying cause, and steroid-related cardiovascular harm, including heart muscle changes and adverse lipid effects, continues regardless of blood pressure readings.

Anyone with elevated blood pressure should have it confirmed with proper measurements, ideally including home or ambulatory monitoring, and evaluated by a physician who can look at all contributing factors.

Editorial Team Conclusions

Amlodipine is an effective, long-acting calcium channel blocker with strong outcome data for hypertension and angina.

Its main side effects, ankle swelling, flushing, headache and dizziness, are related to vasodilation and are often dose-dependent and manageable with your doctor's help.

Caution is needed in severe aortic stenosis, low blood pressure, heart failure and liver disease, and interactions with drugs such as simvastatin must be considered.

For related reading, see our articles on blood pressure in strength athletes, how anabolic steroids affect the heart, and how to measure blood pressure correctly at home.

References

1. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981–2997.
2. Dahlöf B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet. 2005;366(9489):895–906.
3. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Hypertension. 2018;71(6):e13–e115.
4. Makani H, Bangalore S, Romero J, et al. Peripheral edema associated with calcium channel blockers: incidence and withdrawal rate — a meta-analysis of randomized trials. J Hypertens. 2011;29(7):1270–1280.
5. Pfizer. NORVASC (amlodipine besylate) tablets: prescribing information. New York: Pfizer; revised periodically.
6. Pope HG Jr, Wood RI, Rogol A, et al. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014;35(3):341–375.